Tag archive for ‘Allergan’
Jewish Business News On Monday, February 26th, 2018

Allergen, The Mohawk Indian Tribe and What is The Connection to Teva

  The creative attempt by the drug company Allergan to fight generic competition by Mylan and Teva failed, and not for the first time. The appeals committee of the US Patent Office on Friday rejected an More...

Jewish Business News On Monday, November 6th, 2017

Len Blavatnik examines $3 billion investment in Teva

    Billionaire Len Blavatnik is considering investing $ 3 billion in Teva Pharmaceutical Industries, The Marker has learned. Blavatnik may acquire a significant share of Teva if the company is trading More...

Gil Tanenbaum On Wednesday, November 16th, 2016

Carl Icahn Takes a Bath On Allergan and Federal-Mogul

  Carl Icahn, one of the world’s biggest activist investors, is having trouble with two of his recent positions. The first is in Allergan and the second is in auto parts maker Federal-Mogul. According More...

Teva completes acquisition of Allergan’s generics business – Actavis Generics

  Teva Pharmaceutical Industries Ltd. and Allergan plc today announced that Teva has completed its acquisition of Allergan’s generics business – Actavis Generics. Allergan received $33.43 billion More...

Teva buys Allergan distributor Anda for $500 million

  One day after Teva Pharmaceutical Industries closed its deal to buy Allergan’s generics business for $33.43 billion in cash and $5.3 billion in shares, the company purchase Allergan’s 4th largest More...

Ilan Shavit On Thursday, February 18th, 2016

Teva offering concessions for Allergan takeover – Bloomberg

  Teva Pharmaceutical Industries Ltd. will try to win fast European Union approval for its takeover of Allergan’s generics unit by making concessions to regulators, according to “Bloomberg” More...

AAI Letter to the FTC: Generic pharmaceutical merger TEVA and ALLERGAN Will Eliminate Important Competition

In a letter to the Federal Trade Commission (FTC), The American Antitrust Institute (AAI), a non-profit organization, outlined the competitive concerns raised by the proposed merger of generic pharmaceutical More...

Teva raises extra $658 million in underwriters’ options

The underwriters for Teva Pharmaceutical Industries’ share offering last month have exercised their over-allotment option to purchase additional shares worth $658 million. Following the exercising of these More...

Jewish Business News On Monday, November 30th, 2015

Teva to Sell $6.75 Billion in Stock to Buy Allergan Unit, Rimsa

  Teva Pharmaceutical Industries Ltd has announced today two offerings totaling approximately $6.75 billion of ordinary and preferred shares to fund its takeover of Allergan Plc’s generic-drug business More...

News Brief On Wednesday, November 25th, 2015

Pfizer to become Teva’s largest shareholder

  One of the side aspects of the pending Pfizer (PFE)-Allergan (AGN) deal, is that Pfizer will end up owning a 10 percent share in Israel-based Teva Pharmaceutical Industries Ltd. (TEVA) In July, Teva More...

Wordpress site Developed by Fixing WordPress Problems